JPY 1149.0
(1.86%)
Breakdown | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|
Operating Cash Flow | 1.22 Billion | 1.37 Billion | 472.71 Million | 1.79 Billion |
Net Income | 1.18 Billion | 994.34 Million | 724.79 Million | 711.23 Million |
Depreciation & Amortization | 616.36 Million | 532.42 Million | 504.46 Million | 364.36 Million |
Deferred income taxes | - | - | - | - |
Stock-based compensation | - | - | - | - |
Change in working capital | -302.8 Million | 246.72 Million | -669.99 Million | 704.23 Million |
Other non-cash items | 87.41 Million | -44.92 Million | -28.54 Million | 97.06 Million |
Investing Cash Flow | -722.39 Million | -679.56 Million | -635.75 Million | -680.94 Million |
Investments in PPE | -716.14 Million | -679.97 Million | -642.43 Million | -680.22 Million |
Acquisitions | - | - | - | - |
Investment purchases | - | - | - | - |
Sales/Maturities of investments | - | - | - | - |
Other Investing Activities | -6.25 Million | 414 Thousand | 6.67 Million | -720 Thousand |
Financing Cash Flow | -229.05 Million | 333.87 Million | -263.25 Million | -101.34 Million |
Debt repayment | -137.99 Million | -500.59 Million | -197.21 Million | -99.99 Million |
Dividends payments | -141.15 Million | -102.25 Million | -54.42 Million | -52.42 Million |
Common Stock Repurchased | -65 Thousand | - | -11.61 Million | -2.72 Million |
Common Stock Issuance | 66.88 Million | 946.08 Million | - | 53.79 Million |
Other Financing Activities | 49 Million | -798 Thousand | -1000.00 | -2.72 Million |
Accounts receivables | -2.02 Billion | -137 Million | -1.33 Billion | 158.93 Million |
Accounts payables | 1.03 Billion | 1 Billion | 641.48 Million | 525.42 Million |
Inventory | 491.96 Million | -595.62 Million | -188.3 Million | 27.24 Million |
Other working capital | 115 Million | -3 Million | 156.79 Million | 57.73 Million |
Cash at beginning of period | 3.89 Billion | 2.86 Billion | 3.29 Billion | 2.28 Billion |
Cash at end of period | 4.16 Billion | 3.89 Billion | 2.86 Billion | 3.29 Billion |
Capital Expenditure | -716.14 Million | -679.97 Million | -642.43 Million | -680.22 Million |
Effect of forex changes on cash | 188 Thousand | 429 Thousand | 279 Thousand | -229 Thousand |
Net cash flow / Change in cash | 272.8 Million | 1.03 Billion | -426.01 Million | 1 Billion |
Free Cash Flow | 507.93 Million | 697.2 Million | -169.71 Million | 1.11 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 204.69 Million | 273.36 Million | 1.18 Billion | 389.32 Million | 198.24 Million | 262.56 Million |
Depreciation & Amortization | 155.85 Million | 151.92 Million | 616.36 Million | 159.78 Million | 158.53 Million | 156.34 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 47.46 Million | 655.34 Million | -302.8 Million | -131.51 Million | 2.02 Billion | -503.82 Million |
Other non-cash items | 363.11 Million | 51.9 Million | 87.41 Million | -5.81 Million | 12.68 Million | -21.34 Million |
Investing Cash Flow | -196.75 Million | -186.4 Million | -722.39 Million | -183.11 Million | -168.85 Million | -148.17 Million |
Investments in PPE | -196.93 Million | -186.4 Million | -716.14 Million | -177.45 Million | -169 Million | -147.86 Million |
Acquisitions | - | - | - | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | 181 Thousand | -184 Million | -6.25 Million | -5.35 Million | -155 Thousand | -312 Thousand |
Financing Cash Flow | -8.78 Million | -222.6 Million | -229.05 Million | 13.78 Million | 18.55 Million | -2.6 Million |
Debt repayment | -13.33 Million | -13.33 Million | -137.99 Million | -13.33 Million | -8.88 Million | -13.33 Million |
Dividends payments | -439 Thousand | -211.75 Million | -141.15 Million | - | -1000.00 | -390 Thousand |
Common Stock Repurchased | - | - | -65 Thousand | - | - | -65 Thousand |
Common Stock Issuance | 4.11 Million | 2.47 Million | 66.88 Million | 27.12 Million | 27.44 Million | 10.4 Million |
Other Financing Activities | 4 Million | 1000.00 | 49 Million | 26 Million | 28 Million | 10 Million |
Accounts receivables | 410.94 Million | 1.22 Billion | -2.02 Billion | -1.82 Billion | 179 Million | -561 Million |
Accounts payables | -514.62 Million | 131.99 Million | 1.03 Billion | 1.26 Billion | 1.55 Billion | -175.33 Million |
Inventory | 125.92 Million | -409.13 Million | 491.96 Million | 310.25 Million | 197.1 Million | 184.85 Million |
Other working capital | 25.21 Million | -74 Million | 115 Million | 51 Million | 33 Million | 31 Million |
Cash at beginning of period | 4.68 Billion | 4.16 Billion | 3.89 Billion | 3.92 Billion | 1.84 Billion | 2.09 Billion |
Cash at end of period | 4.96 Billion | 4.68 Billion | 4.16 Billion | 4.16 Billion | 3.92 Billion | 1.84 Billion |
Capital Expenditure | -196.93 Million | -186.4 Million | -716.14 Million | -177.45 Million | -169 Million | -147.86 Million |
Effect of forex changes on cash | 239 Thousand | 284 Thousand | 188 Thousand | -222 Thousand | 112 Thousand | 278 Thousand |
Net cash flow / Change in cash | 276.37 Million | 515.93 Million | 272.8 Million | 249.4 Million | 2.07 Billion | -257.1 Million |
Free Cash Flow | 284.74 Million | 738.25 Million | 507.93 Million | 241.5 Million | 2.05 Billion | -254.47 Million |
XGN
RKKE
600287
ODMUF
BIOX
7062